Full Breakdown
States Accelerate Kratom Restrictions Amid Pending Federal Rule
8/15/2026, 8:46:01 PM
Core Event: State Emergency Orders Target Kratom
In the summer of 2026, multiple states issued emergency orders classifying all forms of kratom—or its potent chemical 7-hydroxymitragynine (7-OH)—as Schedule I substances. Massachusetts announced the measure on August 13, 2026, with enforcement slated for August 28, 2026 after a mandatory notice period. North Dakota declared a public-health emergency banning the sale, use and possession of kratom statewide. Florida’s attorney general signed an emergency rule limiting the concentration of 7-OH in consumer products. These actions precede a narrower federal proposal that would temporarily place 7-OH and three related compounds in Schedule I while leaving the raw plant unregulated.
Background & Context
Kratom is a tropical tree native to Southeast Asia, related to the coffee plant. Low doses produce stimulant-like effects; higher doses act similarly to opioids. Because the U.S. Food and Drug Administration does not regulate kratom, the product is sold in powders, capsules, gummies, tablets and dissolvable strips at gas stations, smoke shops and online. Health officials have linked concentrated 7-OH products to seizures, hallucinations, dependence, withdrawal symptoms and, in Florida, at least 587 overdose deaths since 2013.
Data & Statistics
- Florida medical examiners have attributed at least 587 overdose deaths to 7-OH–containing products since 2013.
- Massachusetts hospitals reported a marked increase in kratom-related admissions between 2017 and 2024, according to research from Mass General Brigham.
- Roughly ten states maintain full bans on kratom, including neighboring Vermont and Connecticut; other states rely on age limits or quality standards.
Official Statements & Responses
- Governor Maura Healey announced the Massachusetts emergency order, emphasizing the need for an immediate bridge to local regulation.
- Dr. Robbie Goldstein, Massachusetts public-health commissioner, said the goal is to protect the public and ensure treatment access.
- Gov. Kelly Armstrong of North Dakota called the statewide ban a necessary response to a public-health emergency.
- The U.S. Drug Enforcement Administration (DEA) indicated in July that it intends to temporarily schedule 7-OH and three related substances, leaving the raw kratom plant unscheduled as long as its 7-OH content remains below set limits.
- Dr. Cory Howard, emergency physician at Tampa General Hospital, warned that aggressive marketing reaches “infants to the elderly.”
- Dr. Thomas Nappe, addiction-medicine specialist at the same hospital, described severe dependence and withdrawal associated with 7-OH.
On-the-Ground Report: Colorado Retailer
Corey Montenegro, owner of Kiody Kava in Colorado Springs, began selling kratom powder after a decade of prescription-pain medication following back-surgery. He turned to kratom to avoid “addicted to pain pills” and says his pain “was less, a lot less,” illustrating why some consumers view kratom as a self-managed alternative.
Conflicting Reports & Gaps
- Overdose Attribution: Florida cites 587 deaths linked to 7-OH, while other states have not released comparable mortality figures.
- Scope of Federal Action: The DEA’s proposal targets only specific chemicals, not the kratom plant itself, creating a regulatory mismatch with states that have banned the entire herb. No federal agency has provided a definitive timeline for final rulemaking.
What’s Next
- The Massachusetts emergency order becomes active on August 28, 2026 and may remain in effect for up to one year.
- North Dakota’s special legislative session scheduled for early September will determine whether the emergency ban becomes permanent state law.
- The DEA’s temporary scheduling of 7-OH is expected to be reviewed later this year, potentially shaping future federal standards for kratom-derived products.
